BOK Financial’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-18,311
| Closed | -$483K | – | 1483 |
|
|
2024
Q2 | $483K | Buy |
18,311
+31
| +0.2% | +$817 | 0.01% | 615 |
|
|
2024
Q1 | $547K | Buy |
18,280
+2,844
| +18% | +$85K | 0.01% | 566 |
|
|
2023
Q4 | $434K | Sell |
15,436
-2,266
| -13% | -$63.7K | 0.01% | 571 |
|
|
2023
Q3 | $476K | Buy |
17,702
+12,700
| +254% | +$341K | 0.01% | 545 |
|
|
2023
Q2 | $154K | Hold |
5,002
| – | – | ﹤0.01% | 666 |
|
|
2023
Q1 | $180K | Buy |
+5,002
| New | +$180K | ﹤0.01% | 678 |
|
|
2022
Q4 | – | Sell |
-5,002
| Closed | -$201K | – | 933 |
|
|
2022
Q3 | $201K | Hold |
5,002
| – | – | ﹤0.01% | 847 |
|
|
2022
Q2 | $210K | Buy |
+5,002
| New | +$210K | ﹤0.01% | 856 |
|
|
2022
Q1 | – | Sell |
-7,710
| Closed | -$307K | – | 1014 |
|
|
2021
Q4 | $307K | Buy |
+7,710
| New | +$307K | ﹤0.01% | 819 |
|